Provider Alerts
Looking for specific topics? Search the provider Alerts here:
2025
-
Presumptive Eligibility: Best Practices
-
Department of Health Care Services and Medi-Cal’s Outreach and Education Department: Medi-Cal Provider In-Person Training Event
-
Conexiones Primary Care Access Project
-
California Behavioral Health Association 2025 Behavioral Health Policy Forum: Meeting the Moment and Preparing for the Future
-
Community Health Worker (CHW) Benefit Updates
-
DHCS APL 24-019: Minor Consent to Outpatient Mental Health Treatment or Counseling
-
The Department of Healthcare Services Skilled Nursing Facilities Workforce & Quality Improvement Program – File Reconciliation Calendar Year 2024
-
FDA Drug Recall Alert – Ropivacaine Hydrochloride Injection USP, 500 mg/100 mL
-
2025 Income Eligibility Guidelines for the Every Woman Counts (EWC) Program
-
Medi-Cal Pharmacy (Rx) Update – Completion of Pediatric Integration
-
Claims Editing System (CES)- Quarterly Update – April 2025
-
Reminder: DHCS Encounter Requirement – Discharge Hour
-
Reminder: Submit Outstanding Claims and Encounters
-
Department of Health Care Services (DHCS), All Plan Letter (APL) 23-029- Memorandum of Understanding Requirements for Medi-Cal Managed Care Plans and Third-Party Entities
-
Medical Benefit Update – Effective June 9, 2025
-
3rd Annual Black Maternal Health Symposium- San Joaquin County
-
Save the Date: Events in Partnership with Valley Children’s Healthcare – April 2025
-
Medi-Cal In-Person Training Event – April 2025
-
Member Resources for Navigating Medi-Cal and Federal Immigration Changes
-
FDA Drug Recall Alert – Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL
Posted on July 17th, 2015 and last modified on January 22nd, 2025.
top